Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer Related Pain

NCT03146806 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03146806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03146806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer Related Pain
Lead sponsor
Emory University
Phase
Phase 1/2
Overall status
Completed
Start date
July 25, 2017
Completion date
April 22, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pain